These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 21677651

  • 1. Persistent increase in hypothalamic arginine vasopressin gene expression during protracted withdrawal from chronic escalating-dose cocaine in rodents.
    Zhou Y, Litvin Y, Piras AP, Pfaff DW, Kreek MJ.
    Neuropsychopharmacology; 2011 Sep; 36(10):2062-75. PubMed ID: 21677651
    [Abstract] [Full Text] [Related]

  • 2. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y, Spangler R, Schlussman SD, Ho A, Kreek MJ.
    Brain Res; 2003 Feb 28; 964(2):187-99. PubMed ID: 12576179
    [Abstract] [Full Text] [Related]

  • 3. Amygdalar vasopressin mRNA increases in acute cocaine withdrawal: evidence for opioid receptor modulation.
    Zhou Y, Bendor JT, Yuferov V, Schlussman SD, Ho A, Kreek MJ.
    Neuroscience; 2005 Feb 28; 134(4):1391-7. PubMed ID: 16039786
    [Abstract] [Full Text] [Related]

  • 4. Persistent increases in rat hypothalamic POMC gene expression following chronic withdrawal from chronic "binge" pattern escalating-dose, but not steady-dose, cocaine.
    Zhou Y, Kreek MJ.
    Neuroscience; 2015 Mar 19; 289():63-70. PubMed ID: 25595971
    [Abstract] [Full Text] [Related]

  • 5. Restraint-induced corticosterone secretion and hypothalamic CRH mRNA expression are augmented during acute withdrawal from chronic cocaine administration.
    Mantsch JR, Taves S, Khan T, Katz ES, Sajan T, Tang LC, Cullinan WE, Ziegler DR.
    Neurosci Lett; 2007 Mar 30; 415(3):269-73. PubMed ID: 17293045
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of the arginine vasopressin Avp1b receptor in the acute neuroendocrine action of antidepressants.
    Stewart LQ, Roper JA, Young WS, O'Carroll AM, Lolait SJ.
    Psychoneuroendocrinology; 2008 May 30; 33(4):405-15. PubMed ID: 18243568
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin.
    Zhou Y, Leri F, Cummins E, Hoeschele M, Kreek MJ.
    Neuropsychopharmacology; 2008 Jan 30; 33(2):226-36. PubMed ID: 17443128
    [Abstract] [Full Text] [Related]

  • 11. Differential actions of acute and chronic citalopram on the rodent hypothalamic-pituitary-adrenal axis response to acute restraint stress.
    Hesketh S, Jessop DS, Hogg S, Harbuz MS.
    J Endocrinol; 2005 Jun 30; 185(3):373-82. PubMed ID: 15930163
    [Abstract] [Full Text] [Related]

  • 12. Acute Mono-Arthritis Activates the Neurohypophysial System and Hypothalamo-Pituitary Adrenal Axis in Rats.
    Nishimura H, Kawasaki M, Matsuura T, Suzuki H, Motojima Y, Baba K, Ohnishi H, Yamanaka Y, Fujitani T, Yoshimura M, Maruyama T, Ueno H, Sonoda S, Nishimura K, Tanaka K, Sanada K, Onaka T, Ueta Y, Sakai A.
    Front Endocrinol (Lausanne); 2020 Jun 30; 11():43. PubMed ID: 32117068
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
    Makino S, Smith MA, Gold PW.
    Endocrinology; 1995 Aug 30; 136(8):3299-309. PubMed ID: 7628364
    [Abstract] [Full Text] [Related]

  • 15. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
    Costa A, Nappi RE, Polatti F, Poma A, Grossman AB, Nappi G.
    Exp Neurol; 2000 Dec 30; 166(2):376-84. PubMed ID: 11085902
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons.
    Zelena D, Mergl Z, Makara GB.
    Brain Res; 2005 Jan 21; 1031(2):185-93. PubMed ID: 15649443
    [Abstract] [Full Text] [Related]

  • 18. Immunotargeted lesions of paraventricular CRF and AVP neurons in developing rats reveal the pattern of maturation of these systems and their functional importance.
    Walker CD, Tankosic P, Tilders FJ, Burlet A.
    J Neuroendocrinol; 1997 Jan 21; 9(1):25-41. PubMed ID: 9023736
    [Abstract] [Full Text] [Related]

  • 19. Acute glucocorticoid pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis hormone secretion and expression of corticotropin-releasing hormone hnRNA but does not affect c-fos mRNA or fos protein expression in the paraventricular nucleus of the hypothalamus.
    Ginsberg AB, Campeau S, Day HE, Spencer RL.
    J Neuroendocrinol; 2003 Nov 21; 15(11):1075-83. PubMed ID: 14622438
    [Abstract] [Full Text] [Related]

  • 20. Effect of naloxone-precipitated morphine withdrawal on CRH and vasopressin mRNA expression in the rat hypothalamic paraventricular nucleus.
    Milanés MV, Laorden ML, Angel E, Tankosic P, Burlet A.
    Neurosci Lett; 2002 Dec 06; 334(1):58-62. PubMed ID: 12431775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.